RW-108

N/A

Report date: 2025/09/03 17:58:20
NME

Base Information

Drug NameRW-108
Drug Alias NameRW-108
ClassificationSmall molecules
Mechanisms of ActionAdenosine A2 receptor antagonists
TargetsAdenosine A2 receptor
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRiverWalk Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRiverWalk Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A